• NORD Partners with ‘Sing Me a Story’ for July 18–20 Living Rare Forum
  • Kicking Alcohol Changed My Ankylosing Spondylitis Experience
  • Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19
  • Fatigue in Ankylosing Spondylitis Warrants Greater Focus, Study Says
  • Balance Your Anxiety and Concern About COVID-19
  • Anti-Inflammatories Linked to Lower Use of Psychotropic Medications in AS Patients
  • 2nd Humira Biosimilar Seen as Effective and Safe in Phase 3 Trial in China
  • Everything You’ve Ever Wanted to Know About AS
  • Pediatric Rare Disease Therapies Increase, But Most Repurposed, Study Finds
  • TNF Blockers Show Real-life Benefits in Patients, Study Finds
  • FDA Approves Higher Cosentyx Dose for Active AS
  • Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare